bpc 157 dosage mcg daily injury healing BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not BPC 157 Dosage: A Doctor's
Description
You must confirm your public display name before commenting Please logout and then login again, you will then be prompted to enter your display name
For maximum anti-aging effect, GHK-Cu is superior
In animal models, intranasal administration of GHK-Cu improved cognitive functions, reduced amyloid plaques, and decreased inflammation in the brain, suggesting its potential as a therapeutic agent for Alzheimers disease and age-related cognitive decline 10
doi: 10.1007/s00018-011-0905-1
DSIP
